Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancerM Markman, T Hakes, B Reichman, et al.Gynecologic Oncology|November 5, 1997
High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-upF Shapiro, J Schneider, M Markman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsyR R Barakat, T A Gilewski, L Almadrones, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1991
Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancerM Markmann, R Rothman, B Reichman, et al.Gynecologic Oncology|June 11, 1991
Late effects of cisplatin-based chemotherapy on renal function in patients with ovarian carcinomaM Markman, R Rothman, T Hakes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 1991
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatinM Markman, R Rothman, T Hakes, et al.Gynecologic Oncology|May 8, 1998
A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessmentR R Barakat, L Almadrones, E S Venkatraman, et al.Gynecologic Oncology|November 11, 1991
Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapyB Reichman, M Markman, T Hakes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1992
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant diseaseM Markman, T Hakes, B Reichman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancerM Markman, M George, T Hakes, et al.Pageof 5